Filing Details
- Accession Number:
- 0001683168-23-002562
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-21 07:58:55
- Reporting Period:
- 2023-04-19
- Accepted Time:
- 2023-04-21 07:58:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1729427 | Cns Pharmaceuticals Inc. | CNSP | Pharmaceutical Preparations (2834) | 822318545 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1793252 | Jerzy Gumulka | C/O Cns Pharmaceuticals, Inc. 100 West Loop South, Suite 900 Houston TX 77027 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-19 | 2,500 | $1.70 | 9,673 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
